According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$15.74. In 2022 the company made an earnings per share (EPS) of -$18.94 a decrease over its 2021 EPS that were of -$17.87.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$15.74 | -16.9% |
2022 | -$18.94 | 5.99% |
2021 | -$17.87 | -16.1% |
2020 | -$21.30 | -26.3% |
2019 | -$28.90 | -125.06% |
2018 | $115.35 | -336.62% |
2017 | -$48.75 | -46.37% |
2016 | -$90.90 | -29.53% |
2015 | -$129.00 | -27.06% |
2014 | -$176.85 | 31.29% |
2013 | -$134.70 | 83.27% |
2012 | -$73.50 | -64.34% |
2011 | -$206.10 | 109.13% |
2010 | -$98.55 | 131.78% |
2009 | -$42.52 | 372.42% |
2008 | -$9.00 | -1.64% |
2007 | -$9.15 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -189.49% | ๐บ๐ธ USA |
Pfizer PFE | $1.86 | -111.82% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | -118.88% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $37.36 | -337.36% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | -$0.22 | -98.60% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | -$0.75 | -95.24% | ๐บ๐ธ USA |